How Well-Supported Is The Current Technology Vendor Space?
Source: bio-techne
In this segment from the Cell & Gene Live event Considerations For Investing In Your Gene Therapy’s Automation Framework, TJ Cradick, Ph.D., CSO of Excision BioTherapeutics, and Matt Humes, head of lab automation at Beam Therapeutics, talk about the current technological landscape — how well industry needs are being met and where there is room for improvement.
access the Video!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.
Subscribe to Cell & Gene
X
Subscribe to Cell & Gene
bio-techne
This website uses cookies to ensure you get the best experience on our website. Learn more